StockpollyBeta
Get App
Delisting riskPopularity #4,213
CELZ · NASDAQ · Biotechnology

Creative Medical Technology (CELZ)

Develops regenerative cell therapies for pain and diabetes alongside physician-use procedure kits.

$0.9120
After hours−0.01 (−0.87%)
At close$0.9200(−8.46%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Insiders0.01%351 shares
1 holder · as of Feb 20, 2025
Other99.99%2.58M shares
remainder

2.58M company shares as of Aug 27, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Michael H. FingerInsiderdirector
0.01%351filed Feb 20, 2025
Altium Capital Management, LPInstitution
—4.99% of class, as filed—filed Feb 14, 2022
Growth GP, LLCStrategic
—5.70% of class, as filed—filed Dec 20, 2021
Heights Capital Management, Inc.Strategic
—5.20% of class, as filed—filed Dec 10, 2021
John MarkeyInsider
—5.10% of class, as filed—filed May 2, 2023
L1 Capital Global Opportunities Master Fund Ltd.Institution
—5.10% of class, as filed—filed Dec 8, 2021
Creative Medical Health Inc.1Strategic10 percent owner
0.88%22,695filed Jan 8, 2021
Timothy Warbington2Insiderdirector, officer: President & CEO
0.47%12,209filed Jun 29, 2023
Thomas Ichim3Insiderdirector
0.04%906filed Jul 22, 2021
Timothy Herbst4Insider10 percent owner
0.00%15filed Jan 27, 2017
Amit Nilkanth Patel5Insiderdirector
0.00%5filed Oct 24, 2016
Donald Dickerson6Insiderdirector, officer: CFO & Sr.VP
0.00%2filed Oct 26, 2016
  1. Last filed Jan 8, 2021; leaving the company requires no filing. Not in the bar.
  2. Last filed Jun 29, 2023; leaving the company requires no filing. Not in the bar.
  3. Last filed Jul 22, 2021; leaving the company requires no filing. Not in the bar.
  4. Last filed Jan 27, 2017; leaving the company requires no filing. Not in the bar.
  5. Last filed Oct 24, 2016; leaving the company requires no filing. Not in the bar.
  6. Last filed Oct 26, 2016; leaving the company requires no filing. Not in the bar.

13F

No 13F holders on record.

13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Form 4

Latest trades

Nothing filed in the last 12 months.

House and Senate disclosures

Not reported.